collection
https://read.qxmd.com/read/25998113/young-onset-dementia-epidemiology-applied-to-neuropsychiatry-practice
#21
REVIEW
Bhargavi Devineni, Chiadi U Onyike
A substantial number of adults suffer young-onset dementia (YOD). The diversity of types and syndromes makes recognition and diagnosis difficult. An algorithmic approach to interpreting clinical data, informed by clinical epidemiology, integrates data pertaining to defining syndromes and their chronology and tempo, family history, and other neuropsychiatric features and neurologic signs, is used to reach a preliminary diagnosis and direct diagnostic tests and their interpretation. Screening for YOD in the psychiatric context is a rational process in which vigilance is combined with careful searches for red flags that signal a neurodegenerative etiology...
June 2015: Psychiatric Clinics of North America
https://read.qxmd.com/read/27206231/a-systematic-review-of-neuropsychiatric-comorbidities-in-patients-with-both-epilepsy-and-intellectual-disability
#22
REVIEW
Jans S van Ool, Francesca M Snoeijen-Schouwenaars, Helenius J Schelhaas, In Y Tan, Albert P Aldenkamp, Jos G M Hendriksen
Epilepsy is a neurological condition that is particularly common in people with intellectual disability (ID). The care for people with both epilepsy and ID is often complicated by the presence of neuropsychiatric disorders, defined as psychiatric symptoms, psychiatric disorders, and behavioral problems. The aim of this study was to investigate associations between epilepsy or epilepsy-related factors and neuropsychiatric comorbidities in patients with ID and between ID and neuropsychiatric comorbidities in patients with epilepsy...
July 2016: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/27133416/the-american-psychiatric-association-practice-guideline-on-the-use-of-antipsychotics-to-treat-agitation-or-psychosis-in-patients-with-dementia
#23
JOURNAL ARTICLE
Victor I Reus, Laura J Fochtmann, A Evan Eyler, Donald M Hilty, Marcela Horvitz-Lennon, Michael D Jibson, Oscar L Lopez, Jane Mahoney, Jagoda Pasic, Zaldy S Tan, Cheryl D Wills, Richard Rhoads, Joel Yager
No abstract text is available yet for this article.
May 1, 2016: American Journal of Psychiatry
https://read.qxmd.com/read/26782334/management-of-psychiatric-and-neurological-comorbidities-in-epilepsy
#24
REVIEW
Andres M Kanner
The treatment of epileptic seizure disorders is not restricted to the achievement of seizure-freedom, but must also include the management of comorbid medical, neurological, psychiatric and cognitive comorbidities. Psychiatric and neurological comorbidities are relatively common and often co-exist in people with epilepsy (PWE). For example, depression and anxiety disorders are the most common psychiatric comorbidities in PWE, and they are particularly common in PWE who also have a neurological comorbidity, such as migraine, stroke, traumatic brain injury or dementia...
February 2016: Nature Reviews. Neurology
https://read.qxmd.com/read/26595641/frontotemporal-dementia
#25
REVIEW
Jee Bang, Salvatore Spina, Bruce L Miller
Frontotemporal dementia is an umbrella clinical term that encompasses a group of neurodegenerative diseases characterised by progressive deficits in behaviour, executive function, or language. Frontotemporal dementia is a common type of dementia, particularly in patients younger than 65 years. The disease can mimic many psychiatric disorders because of the prominent behavioural features. Various underlying neuropathological entities lead to the frontotemporal dementia clinical phenotype, all of which are characterised by the selective degeneration of the frontal and temporal cortices...
October 24, 2015: Lancet
https://read.qxmd.com/read/26595643/vascular-dementia
#26
REVIEW
John T O'Brien, Alan Thomas
Vascular dementia is one of the most common causes of dementia after Alzheimer's disease, causing around 15% of cases. However, unlike Alzheimer's disease, there are no licensed treatments for vascular dementia. Progress in the specialty has been difficult because of uncertainties over disease classification and diagnostic criteria, controversy over the exact nature of the relation between cerebrovascular pathology and cognitive impairment, and the paucity of identifiable tractable treatment targets. Although there is an established relation between vascular and degenerative Alzheimer's pathology, the mechanistic link between the two has not yet been identified...
October 24, 2015: Lancet
https://read.qxmd.com/read/26595642/lewy-body-dementias
#27
REVIEW
Zuzana Walker, Katherine L Possin, Bradley F Boeve, Dag Aarsland
The broad importance of dementia is undisputed, with Alzheimer's disease justifiably getting the most attention. However, dementia with Lewy bodies and Parkinson's disease dementia, now called Lewy body dementias, are the second most common type of degenerative dementia in patients older than 65 years. Despite this, Lewy body dementias receive little attention and patients are often misdiagnosed, leading to less than ideal management. Over the past 10 years, considerable effort has gone into improving diagnostic accuracy by refining diagnostic criteria and using imaging and other biomarkers...
October 24, 2015: Lancet
https://read.qxmd.com/read/26583316/deep-clinical-and-neuropathological-phenotyping-of-pick-disease
#28
JOURNAL ARTICLE
David J Irwin, Johannes Brettschneider, Corey T McMillan, Felicia Cooper, Christopher Olm, Steven E Arnold, Vivianna M Van Deerlin, William W Seeley, Bruce L Miller, Edward B Lee, Virginia M-Y Lee, Murray Grossman, John Q Trojanowski
OBJECTIVE: To characterize sequential patterns of regional neuropathology and clinical symptoms in a well-characterized cohort of 21 patients with autopsy-confirmed Pick disease. METHODS: Detailed neuropathological examination using 70μm and traditional 6μm sections was performed using thioflavin-S staining and immunohistochemistry for phosphorylated tau, 3R and 4R tau isoforms, ubiquitin, and C-terminally truncated tau. Patterns of regional tau deposition were correlated with clinical data...
February 2016: Annals of Neurology
https://read.qxmd.com/read/26503923/pathogenesis-of-parkinson-disease-the-gut-brain-axis-and-environmental-factors
#29
REVIEW
Lisa Klingelhoefer, Heinz Reichmann
Parkinson disease (PD) follows a defined clinical pattern, and a range of nonmotor symptoms precede the motor phase. The predominant early nonmotor manifestations are olfactory impairment and constipation. The pathology that accompanies these symptoms is consistent with the Braak staging system: α-synuclein in the dorsal motor nucleus of the vagus nerve, the olfactory bulb, the enteric nervous system (ENS) and the submandibular gland, each of which is a gateway to the environment. The neuropathological process that leads to PD seems to start in the ENS or the olfactory bulb and spreads via rostrocranial transmission to the substantia nigra and further into the CNS, raising the intriguing possibility that environmental substances can trigger pathogenesis...
November 2015: Nature Reviews. Neurology
https://read.qxmd.com/read/26369516/ocular-motor-signatures-of-cognitive-dysfunction-in-multiple-sclerosis
#30
REVIEW
Joanne Fielding, Meaghan Clough, Shin Beh, Lynette Millist, Derek Sears, Ashley N Frohman, Nathaniel Lizak, Jayne Lim, Scott Kolbe, Robert L Rennaker, Teresa C Frohman, Owen B White, Elliot M Frohman
The anatomical and functional overlap between ocular motor command circuitry and the higher-order networks that form the scaffolding for cognition makes for a compelling hypothesis that measures of ocular motility could provide a means to sensitively interrogate cognitive dysfunction in people with multiple sclerosis (MS). Such an approach may ultimately provide objective and reproducible measures of cognitive dysfunction that offer an innovative capability to refine diagnosis, improve prognostication, and more accurately codify disease burden...
November 2015: Nature Reviews. Neurology
https://read.qxmd.com/read/26324301/clinical-approach-to-the-differential-diagnosis-between-behavioral-variant-frontotemporal-dementia-and-primary-psychiatric-disorders
#31
JOURNAL ARTICLE
Simon Ducharme, Bruce H Price, Mykol Larvie, Darin D Dougherty, Bradford C Dickerson
No abstract text is available yet for this article.
September 1, 2015: American Journal of Psychiatry
https://read.qxmd.com/read/22747246/synesthesia
#32
REVIEW
Jamie Ward
Although synesthesia has been known about for 200 years, it is only in the past decade or so that substantial progress has been made in studying it empirically and in understanding the mechanisms that give rise to it. The first part of the review considers the characteristics of synesthesia: its elicited nature, automaticity, prevalence, and consistency, and its perceptual and spatial phenomenology. The second part considers the causes of synesthesia both in terms of candidate neural mechanisms and the distal influences that shape this: genetic differences in developmental synesthesia and plasticity following sensory loss in acquired synesthesia...
2013: Annual Review of Psychology
https://read.qxmd.com/read/23020641/executive-functions
#33
REVIEW
Adele Diamond
Executive functions (EFs) make possible mentally playing with ideas; taking the time to think before acting; meeting novel, unanticipated challenges; resisting temptations; and staying focused. Core EFs are inhibition [response inhibition (self-control--resisting temptations and resisting acting impulsively) and interference control (selective attention and cognitive inhibition)], working memory, and cognitive flexibility (including creatively thinking "outside the box," seeing anything from different perspectives, and quickly and flexibly adapting to changed circumstances)...
2013: Annual Review of Psychology
https://read.qxmd.com/read/26070758/neuropsychiatric-adverse-effects-of-amphetamine-and-methamphetamine
#34
REVIEW
Jaanus Harro
Administration of amphetamine and methamphetamine can elicit psychiatric adverse effects at acute administration, binge use, withdrawal, and chronic use. Most troublesome of these are psychotic states and aggressive behavior, but a large variety of undesirable changes in cognition and affect can be induced. Adverse effects occur more frequently with higher dosages and long-term use. They can subside over time but some persist long-term. Multiple alterations in the gray and white matter of the brain assessed as changes in tissue volume or metabolism, or at molecular level, have been associated with amphetamine and methamphetamine use and the psychiatric adverse effects, but further studies are required to clarify their causal role, specificity, and relationship with preceding states and traits and comorbidities...
2015: International Review of Neurobiology
https://read.qxmd.com/read/26070761/methcathinone-kitchen-chemistry-and-permanent-neurological-damage
#35
REVIEW
Katrin Sikk, Pille Taba
Methcathinone abuse is a significant cause of parkinsonism among young patients in the Eastern European countries. The drug is synthesized from over-the-counter cold remedies containing ephedrine or pseudoephedrine. The final mixture contains a high concentration of manganese if potassium permanganate is used as the oxidant agent. Though manganese is an essential trace element and its homeostasis is well maintained, exposure to a high level of manganese is neurotoxic. The use of manganese-contaminated methcathinone may cause permanent neurological damage and severe disability...
2015: International Review of Neurobiology
https://read.qxmd.com/read/26074754/secondary-psychosis-induced-by-metabolic-disorders
#36
REVIEW
Olivier Bonnot, Paula M Herrera, Sylvie Tordjman, Mark Walterfang
Metabolic disorders are not well-recognized by psychiatrists as a possible source of secondary psychoses. Inborn errors of metabolism (IEMs) are not frequent. Although their prompt diagnosis may lead to suitable treatments. IEMs are well-known to pediatricians, in particular for their most serious forms, having an early expression most of the time. Recent years discoveries have unveiled later expression forms, and sometimes very discreet first physical signs. There is a growing body of evidence that supports the hypothesis that IEMs can manifest as atypical psychiatric symptoms, even in the absence of clear neurological symptoms...
2015: Frontiers in Neuroscience
https://read.qxmd.com/read/25958088/psychiatric-symptoms-in-frontotemporal-dementia-epidemiology-phenotypes-and-differential-diagnosis
#37
REVIEW
Daniela Galimberti, Bernardo Dell'Osso, A Carlo Altamura, Elio Scarpini
Frontotemporal dementia (FTD) is the most frequently occurring dementia in the presenile population. Despite epidemiologic data showing that patients with FTD may have experienced previous psychiatric disorders and that patients with psychotic disorders may develop dementia more often than expected in the nonaffected population, the overlap between these two conditions has been underestimated. Nevertheless, the identification in recent years of several genetic causes of FTD associated with heterogeneous and atypical presentations, including pure psychiatric symptoms, has shifted scientific interest back to obtaining a better understanding of common mechanisms between FTD and psychotic disorders...
November 15, 2015: Biological Psychiatry
https://read.qxmd.com/read/25520742/alexithymia-anxiety-and-depression-in-patients-with-psoriasis-a-case-control-study
#38
JOURNAL ARTICLE
Panagiota Korkoliakou, Christos Christodoulou, Anargyros Kouris, Evgenia Porichi, Vasiliki Efstathiou, Eythymia Kaloudi, Anna Kokkevi, Nikolaos Stavrianeas, Charalabos Papageorgiou, Athanasios Douzenis
BACKGROUND: Alexithymia, the difficulty in describing or recognizing emotions, has been associated with various psychosomatic pathologies including psoriasis. The aim of this study was to examine the prevalence of alexithymia and its association with anxiety and depression in patients with psoriasis compared with healthy participants, while taking into consideration demographic and clinical variables. METHODS: One hundred and eight psoriatic patients and 100 healthy participants from the general population completed the Toronto Alexithymia Scale (TAS-20) and the Hospital Anxiety and Depression Scale (HADS)...
2014: Annals of General Psychiatry
https://read.qxmd.com/read/25763097/intractable-hiccups-singultus-abolished-by-risperidone-but-not-by-haloperidol
#39
Tadashi Nishikawa, Yoichiro Araki, Teruo Hayashi
Hiccups or singulata are rhythmic involuntary movements of the diaphragm, caused by a variety of conditions that interfere with the functions of the nerve nuclei in the medulla and supra-spinal hiccup center. Although neurotransmitters and receptors involved in the pathophysiology of hiccups are not defined well, dopamine has been considered to play an important role. In some cases, chlorpromazine or other antipsychotics are used for the treatment of intractable hiccups but their efficacy is often limited. This report involves an 18-year-old patient who experienced two episodes of intractable hiccups triggered by stress, which lasted for weeks or even months...
2015: Annals of General Psychiatry
https://read.qxmd.com/read/25941467/neuropsychiatric-disorders-in-cushing-s-syndrome
#40
REVIEW
Rosario Pivonello, Chiara Simeoli, Maria Cristina De Martino, Alessia Cozzolino, Monica De Leo, Davide Iacuaniello, Claudia Pivonello, Mariarosaria Negri, Maria Teresa Pellecchia, Felice Iasevoli, Annamaria Colao
Endogenous Cushing's syndrome (CS), a rare endocrine disorder characterized by cortisol hypersecretion, is associated with psychiatric and neurocognitive disorders. Major depression, mania, anxiety, and neurocognitive impairment are the most important clinical abnormalities. Moreover, patients most often complain of impairment in quality of life, interference with family life, social, and work performance. Surprisingly, after hypercortisolism resolution, despite the improvement of the overall prevalence of psychiatric and neurocognitive disorders, the brain volume loss at least partially persists and it should be noted that some patients may still display depression, anxiety, panic disorders, and neurocognitive impairment...
2015: Frontiers in Neuroscience
label_collection
label_collection
4051
2
3
2015-05-11 10:16:21
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.